Nutriband Inc. Secures U.S. Patent for Innovative Abuse-Deterrent Transdermal Technology

The recent granting of U.S. patent No. 12,318,492 to Nutriband Inc. for its 'Abuse and Misuse Deterrent Transdermal Systems' represents a pivotal advancement in pharmaceutical technology. This patent not only solidifies Nutriband's position in the market but also underscores the importance of developing safer drug delivery systems. The Aversa(TM) technology, at the heart of this innovation, is designed to prevent the abuse, misuse, diversion, and accidental exposure of drugs with high abuse potential, such as fentanyl.

The implications of this patent are far-reaching. With the opioid crisis continuing to devastate communities across the United States, the development of abuse-deterrent formulations is more critical than ever. Nutriband's Aversa Fentanyl, which aims to be the first abuse-deterrent fentanyl patch on the market, could significantly reduce the risks associated with fentanyl misuse. The projected peak U.S. sales potential of between $80 million and $200 million highlights the market's readiness for such innovations.

This development is not just a win for Nutriband but for public health at large. By providing a safer alternative to traditional transdermal patches, Nutriband is addressing a critical need in the pharmaceutical industry and offering hope in the ongoing battle against drug abuse. The patent enhances the company's intellectual property portfolio and paves the way for future innovations in abuse-deterrent technologies.

The significance of this patent extends beyond the pharmaceutical industry. It represents a step forward in the global effort to combat drug abuse, offering a tangible solution to a problem that affects millions. As Nutriband continues to develop and commercialize its Aversa(TM) technology, the potential to save lives and reduce the societal impact of drug abuse is immense. This is a clear example of how innovation in pharmaceutical technology can have a profound impact on public health and safety.